{"id":3980,"date":"2020-10-26T12:52:11","date_gmt":"2020-10-26T12:52:11","guid":{"rendered":"https:\/\/blog.caixaresearch.org\/?p=3980"},"modified":"2020-11-03T14:30:06","modified_gmt":"2020-11-03T14:30:06","slug":"lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19","status":"publish","type":"post","link":"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/","title":{"rendered":"L\u2019\u00e8xit dels tractaments ja disponibles per a pacients amb COVID-19"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">El dia 22 de setembre va comen\u00e7ar el nou Cicle de Debats d\u2019Avantguarda de la Fundaci\u00f3 \u201dla Caixa\u201d per donar valor a la recerca, ja que cada dia ens permet tractar amb \u00e8xit m\u00e9s malalties i, en alguns casos, guarir-les.<\/span><\/p>\n<p><span style=\"font-weight: 400;\"><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/PIFMpXBs63M\" width=\"400\" height=\"220\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/span><\/p>\n<p><span style=\"font-weight: 400;\">Aquest cicle dona veu als professionals de la recerca i de la salut que reben ajuts de la Fundaci\u00f3 \u201dla Caixa\u201d, i en la seva primera edici\u00f3 vam parlar \u2013com no podia ser d\u2019una altra manera\u2013 sobre la COVID-19 amb dos cient\u00edfics de reputaci\u00f3 internacional: el Dr. Bonaventura Clotet, director d\u2019IrsiCaixa i cap del Servei de Malalties Infeccioses de l\u2019Hospital Germans Trias i Pujol de Badalona, i el Dr. Valent\u00ed Fuster, director general de CNIC Madrid, director de l\u2019Institut Cardiovascular i Physician-in-Chief del Mount Sinai Medical Center de Nova York. El debat va ser moderat per Josep Corbella, periodista de LA VANGUARDIA especialitzat en ci\u00e8ncia i salut.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Els investigadors van posar en com\u00fa els coneixements recollits fins ara sobre els tractaments actuals i futurs contra la COVID-19.\u00a0<\/span><\/p>\n<p><span style=\"font-weight: 400;\">Entre les conclusions del debat, destaca el fet que ja s\u2019ha aconseguit reduir molt les taxes de mortalitat d\u2019aquesta malaltia, fet que els investigadors van atribuir a:<\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Un millor coneixement de la COVID-19 gr\u00e0cies a la col\u00b7laboraci\u00f3 de cient\u00edfics de tot el m\u00f3n. Una col\u00b7laboraci\u00f3 que mai abans havia estat tan eficient ni tan r\u00e0pida.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Ara sabem que \u00e9s important l\u2019ingr\u00e9s hospitalari i\/o el tractament espec\u00edfic abans d\u2019arribar a quadres cl\u00ednics molt greus.<\/span><\/li>\n<li style=\"font-weight: 400;\"><span style=\"font-weight: 400;\">Tenim tractaments que han demostrat millorar la superviv\u00e8ncia dels pacients. Tots dos investigadors van coincidir que els nous tractaments milloraran encara m\u00e9s amb la combinaci\u00f3 d\u2019antivirals, anticoagulants i antiinflamatoris.<\/span><\/li>\n<\/ul>\n<p><span style=\"font-weight: 400;\">Sobre la vacuna, tamb\u00e9 hi va haver consens entre els experts: arribar\u00e0, per\u00f2 no de manera generalitzada abans d\u2019uns dos anys.<\/span><\/p>\n<p><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-full wp-image-3978\" src=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg\" alt=\"\" width=\"400\" height=\"300\" srcset=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg 800w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP-300x225.jpg 300w, https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP-768x576.jpg 768w\" sizes=\"auto, (max-width: 400px) 100vw, 400px\" \/><\/p>\n<p><span style=\"font-weight: 400;\">Una de les complicacions derivades d\u2019aquesta malaltia \u00e9s la formaci\u00f3 de trombes o co\u00e0guls a la sang que, al seu torn, poden desencadenar greus problemes cardiovasculars. Per investigar-ne l\u2019efecte, el Dr. Fuster va dirigir un estudi a l\u2019Hospital de Mount Sinai amb m\u00e9s de 2.700 pacients tractats amb anticoagulants despr\u00e9s de ser hospitalitzats amb COVID-19. \u201cAl cap de molt pocs mesos, vam veure que el grup que es tractava amb anticoagulants tenia una disminuci\u00f3 de la mortalitat d\u2019un 50 %, i tamb\u00e9 un 30 % menys de possibilitats de ser intubats\u201d, detalla Fuster. Recentment, el Dr. Fuster ha comen\u00e7at un estudi amb 70 institucions internacionals per avaluar l\u2019efecte de diversos anticoagulants a l\u2019espera d\u2019obtenir resultats d\u2019aqu\u00ed a tres mesos.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">D\u2019altra banda, el Dr. Clotet ha dirigit un estudi internacional coordinat des del Servei de Malalties Infeccioses de l\u2019Hospital Germans Trias amb m\u00e9s de 1.000 pacients de COVID-19 en qu\u00e8 ha investigat l\u2019efecte d\u2019un antiviral conegut com <\/span><i><span style=\"font-weight: 400;\">remdesivir<\/span><\/i><span style=\"font-weight: 400;\">. Els resultats d\u2019aquest estudi demostren que aquest tractament antiviral \u00e9s m\u00e9s efica\u00e7 si s\u2019administra en pacients greus abans que requereixin ventilaci\u00f3 mec\u00e0nica, de manera que redueix l\u2019estada hospital\u00e0ria i, en \u00faltima inst\u00e0ncia, la mortalitat. Clotet assegura que \u201cel remdesivir \u00e9s un f\u00e0rmac que t\u00e9 un gran futur, per\u00f2 que tamb\u00e9 sortiran altres tractaments, com f\u00e0rmacs que combinen antivirals amb antiinflamatoris\u201d. Respecte a aix\u00f2, el Dr. Fuster afegeix que \u201cseria un somni que en el futur puguem tractar aquest tipus d\u2019epid\u00e8mies amb una polip\u00edndola. \u00c9s un concepte atractiu\u201d.<\/span><\/p>\n<p><span style=\"font-weight: 400;\">El <\/span><a href=\"https:\/\/fundacionlacaixa.org\/es\/ciclo-debates-health-sight\"><span style=\"font-weight: 400;\">Cicle de Debats d&#8217;Avantguarda, Investigaci\u00f3 i Salut<\/span><\/a>\u00a0<span style=\"font-weight: 400;\">t\u00e9 una periodicitat mensual, i en debats posteriors parlarem sobre altres malalties com ara el c\u00e0ncer o la malaltia d\u2019Alzheimer. No te\u2019ls perdis!<\/span><\/p>\n<p>Llegeix la cr\u00f2nica d\u2019altres debats:<\/p>\n<ul>\n<li><a href=\"https:\/\/blog.caixaresearch.org\/ca\/cancer-cap-a-on-sorienten-les-noves-terapies\/\">C\u00e0ncer. Cap a on s\u2019orienten les noves ter\u00e0pies?<\/a>\u00a0Amb la Dra. Mar\u00eda Blasco (CNIO) i el Dr. Josep Tabernero (VHIO). <em>20\/10\/2020<\/em><\/li>\n<\/ul>\n","protected":false},"excerpt":{"rendered":"<p>El dia 22 de setembre va comen\u00e7ar el nou Cicle de Debats d\u2019Avantguarda de la Fundaci\u00f3 \u201dla Caixa\u201d per donar valor a la recerca, ja que cada dia ens permet tractar amb \u00e8xit m\u00e9s malalties i, en alguns casos, guarir-les.<\/p>\n<p><iframe loading=\"lazy\" src=\"https:\/\/www.youtube.com\/embed\/PIFMpXBs63M\" width=\"400\" height=\"220\" frameborder=\"0\" allowfullscreen=\"allowfullscreen\"><\/iframe><\/p>\n<p>Aquest cicle dona veu als professionals de la recerca i de la salut que reben ajuts de la Fundaci\u00f3 \u201dla Caixa\u201d, i en la seva primera edici\u00f3 vam parlar \u2013com no podia ser d\u2019una altra manera\u2013 sobre la COVID-19 amb dos cient\u00edfics de reputaci\u00f3 internacional: el Dr. Bonaventura Clotet, director d\u2019IrsiCaixa i cap del Servei de Malalties Infeccioses de l\u2019Hospital Germans Trias i Pujol de Badalona, i el Dr. Valent\u00ed Fuster,<\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[520,519],"tags":[346,549,550,552,387,506],"class_list":["post-3980","post","type-post","status-publish","format-standard","hentry","category-divulgacio-cientifica","category-investigacio","tag-anticossos","tag-covid-ca","tag-covid19-ca","tag-debats-davantguarda","tag-malaltia-cardiovascular","tag-vacuna-ca"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v24.7 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>L\u2019\u00e8xit dels tractaments ja disponibles per a pacients amb COVID-19 - Blog CaixaCi\u00e8ncia<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/\" \/>\n<meta property=\"og:locale\" content=\"ca_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"L\u2019\u00e8xit dels tractaments ja disponibles per a pacients amb COVID-19 - Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"og:description\" content=\"El dia 22 de setembre va comen\u00e7ar el nou Cicle de Debats d\u2019Avantguarda de la Fundaci\u00f3 \u201dla Caixa\u201d per donar valor a la recerca, ja que cada dia ens permet tractar amb \u00e8xit m\u00e9s malalties i, en alguns casos, guarir-les. Aquest cicle dona veu als professionals de la recerca i de la salut que reben ajuts de la Fundaci\u00f3 \u201dla Caixa\u201d, i en la seva primera edici\u00f3 vam parlar \u2013com no podia ser d\u2019una altra manera\u2013 sobre la COVID-19 amb dos cient\u00edfics de reputaci\u00f3 internacional: el Dr. Bonaventura Clotet, director d\u2019IrsiCaixa i cap del Servei de Malalties Infeccioses de l\u2019Hospital Germans Trias i Pujol de Badalona, i el Dr. Valent\u00ed Fuster,\" \/>\n<meta property=\"og:url\" content=\"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/\" \/>\n<meta property=\"og:site_name\" content=\"Blog CaixaCi\u00e8ncia\" \/>\n<meta property=\"article:published_time\" content=\"2020-10-26T12:52:11+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2020-11-03T14:30:06+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg\" \/>\n<meta name=\"author\" content=\"Ubikmedia\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Escrit per\" \/>\n\t<meta name=\"twitter:data1\" content=\"Ubikmedia\" \/>\n\t<meta name=\"twitter:label2\" content=\"Temps estimat de lectura\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minuts\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/\",\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/\",\"name\":\"L\u2019\u00e8xit dels tractaments ja disponibles per a pacients amb COVID-19 - Blog CaixaCi\u00e8ncia\",\"isPartOf\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg\",\"datePublished\":\"2020-10-26T12:52:11+00:00\",\"dateModified\":\"2020-11-03T14:30:06+00:00\",\"author\":{\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\"},\"inLanguage\":\"ca\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/#primaryimage\",\"url\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg\",\"contentUrl\":\"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg\"},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#website\",\"url\":\"https:\/\/blog.caixaresearch.org\/\",\"name\":\"Blog CaixaCi\u00e8ncia\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/blog.caixaresearch.org\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ca\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca\",\"name\":\"Ubikmedia\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ca\",\"@id\":\"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g\",\"caption\":\"Ubikmedia\"},\"url\":\"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"L\u2019\u00e8xit dels tractaments ja disponibles per a pacients amb COVID-19 - Blog CaixaCi\u00e8ncia","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/","og_locale":"ca_ES","og_type":"article","og_title":"L\u2019\u00e8xit dels tractaments ja disponibles per a pacients amb COVID-19 - Blog CaixaCi\u00e8ncia","og_description":"El dia 22 de setembre va comen\u00e7ar el nou Cicle de Debats d\u2019Avantguarda de la Fundaci\u00f3 \u201dla Caixa\u201d per donar valor a la recerca, ja que cada dia ens permet tractar amb \u00e8xit m\u00e9s malalties i, en alguns casos, guarir-les. Aquest cicle dona veu als professionals de la recerca i de la salut que reben ajuts de la Fundaci\u00f3 \u201dla Caixa\u201d, i en la seva primera edici\u00f3 vam parlar \u2013com no podia ser d\u2019una altra manera\u2013 sobre la COVID-19 amb dos cient\u00edfics de reputaci\u00f3 internacional: el Dr. Bonaventura Clotet, director d\u2019IrsiCaixa i cap del Servei de Malalties Infeccioses de l\u2019Hospital Germans Trias i Pujol de Badalona, i el Dr. Valent\u00ed Fuster,","og_url":"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/","og_site_name":"Blog CaixaCi\u00e8ncia","article_published_time":"2020-10-26T12:52:11+00:00","article_modified_time":"2020-11-03T14:30:06+00:00","og_image":[{"url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg","type":"","width":"","height":""}],"author":"Ubikmedia","twitter_card":"summary_large_image","twitter_misc":{"Escrit per":"Ubikmedia","Temps estimat de lectura":"3 minuts"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/","url":"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/","name":"L\u2019\u00e8xit dels tractaments ja disponibles per a pacients amb COVID-19 - Blog CaixaCi\u00e8ncia","isPartOf":{"@id":"https:\/\/blog.caixaresearch.org\/#website"},"primaryImageOfPage":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/#primaryimage"},"image":{"@id":"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/#primaryimage"},"thumbnailUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg","datePublished":"2020-10-26T12:52:11+00:00","dateModified":"2020-11-03T14:30:06+00:00","author":{"@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca"},"inLanguage":"ca","potentialAction":[{"@type":"ReadAction","target":["https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/"]}]},{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/ca\/lexit-dels-tractaments-ja-disponibles-per-a-pacients-amb-covid-19\/#primaryimage","url":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg","contentUrl":"https:\/\/blog.caixaresearch.org\/wp-content\/uploads\/2020\/10\/FusterClotet_ESP.jpg"},{"@type":"WebSite","@id":"https:\/\/blog.caixaresearch.org\/#website","url":"https:\/\/blog.caixaresearch.org\/","name":"Blog CaixaCi\u00e8ncia","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/blog.caixaresearch.org\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ca"},{"@type":"Person","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/2b9d5310c27055b4862191402c387fca","name":"Ubikmedia","image":{"@type":"ImageObject","inLanguage":"ca","@id":"https:\/\/blog.caixaresearch.org\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/ccc66bc497f8ba496f9d06e5a58a91de?s=96&d=mm&r=g","caption":"Ubikmedia"},"url":"https:\/\/blog.caixaresearch.org\/ca\/author\/ubikmedia\/"}]}},"_links":{"self":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/3980","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/comments?post=3980"}],"version-history":[{"count":5,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/3980\/revisions"}],"predecessor-version":[{"id":4006,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/posts\/3980\/revisions\/4006"}],"wp:attachment":[{"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/media?parent=3980"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/categories?post=3980"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blog.caixaresearch.org\/ca\/wp-json\/wp\/v2\/tags?post=3980"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}